Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")

NCT00908947 is registered in ClinicalTrials.gov with C. R. Bard as lead sponsor.

NCT NCT00908947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00908947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")
Lead sponsor
C. R. Bard
Phase
Not applicable
Overall status
Terminated
Start date
February 28, 2011
Completion date
September 19, 2018
Enrollment
173 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

superficial femoral artery stenosis